Company Filing History:
9 out of 1,324 
1 out of 2,202 
Years Active: 1983-2004
Title: Innovations of J Martin Brown
Introduction
J Martin Brown is a notable inventor based in Stanford, CA. He has made significant contributions to the field of radiosensitizers and selective cytotoxic agents. With a total of 10 patents, his work has had a profound impact on cancer treatment methodologies.
Latest Patents
One of his latest patents involves the use of 1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents. This patent discloses a method of using these novel compounds to specifically radiosensitize hypoxic tumor cells. Additionally, some of these compounds are useful as specific cytotoxic agents for these cells. Remarkably, they also demonstrate an unexpected ability to radiosensitize aerobic cells following or preceding a hypoxic incubation with the drug. This innovation provides a basis for selective radiosensitization of tumors compared to normal cells. Furthermore, a novel method for preparing the 1,2,4-benzotriazine oxides is also disclosed in this patent.
Career Highlights
Throughout his career, J Martin Brown has worked with esteemed organizations such as SRI International and the United States of America as represented by the Secretary of. His work has been pivotal in advancing the understanding and application of radiosensitizers in medical treatments.
Collaborations
Some of his notable coworkers include William W Lee and Edward W Grange. Their collaborative efforts have contributed to the success of various projects and innovations in the field.
Conclusion
J Martin Brown's contributions to the field of radiosensitizers and selective cytotoxic agents highlight his innovative spirit and dedication to improving cancer treatment. His patents and collaborations continue to influence the medical community and pave the way for future advancements.